The continuum of physiological impairment during treadmill walking in patients with mild-to-moderate copd: Patient characterization phase of a randomized clinical trial

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  O'Donnell, Denis E ^a   Maltais, François ^b   Porszasz, Janos ^c   Webb, Katherine A ^a   Albers, Frank C ^d   Deng, Qiqi ^d   Iqbal, Ahmar ^e   Paden, Heather A ^d   Casaburi, Richard ^c  

^a QUEEN S UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^d BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; METHYLXANTHINE; MUCOLYTIC AGENT; NEDOCROMIL; SALBUTAMOL;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMAN; INSPIRATORY CAPACITY; LUNG DIFFUSION CAPACITY; LUNG VENTILATION; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; OXYGEN CONSUMPTION; PEAK EXPIRATORY FLOW; PLETHYSMOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FUNCTION; TIDAL VOLUME; TREADMILL EXERCISE; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; COMPLICATION; EXERCISE TEST; FORCED EXPIRATORY VOLUME; LEG; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84900308887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096574     Document Type: Article

References (40)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, et al. (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370: 741-750. (Pubitemid 47321907)
2. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC (2003) Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 58: 388-393. (Pubitemid 36560940)
3. Antonelli-Incalzi R, Imperiale C, Bellia V, Catalano F, Scichilone N, et al. (2003) Do GOLD stages of COPD severity really correspond to differences in health status? Eur Respir J 22: 444-449. (Pubitemid 37114938)
4. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, et al. (1997) Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 127: 1072-1079. (Pubitemid 28012076)
5. Decramer M, Rennard S, Troosters T, Mapel DW, Giardino N, et al. (2008) COPD as a lung disease with systemic consequences-clinical impact, mechanisms, and potential for early intervention. COPD 5: 235-256.
6. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, et al. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 972-977. (Pubitemid 40616945)
7. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF (2006) COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 15: 84-91.
8. Walker PP, Burnett A, Flavahan PW, Calverley PM (2008) Lower limb activity and its determinants in COPD. Thorax 63: 683-689.
9. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, et al. (2008) Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 177: 743-751. (Pubitemid 351490561)
10. Guenette JA, Jensen D, Webb KA, Ofir D, Raghavan N, et al. (2011) Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms. Respiratory physiology & neurobiology 177: 218-227.
11. Ofir D, Laveneziana P,Webb KA, Lam YM, O'Donnell DE (2008) Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 622-629. (Pubitemid 351442169)
12. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653. (Pubitemid 38787999)
13. Barbera JA, Ramirez J, Roca J, Wagner PD, Sanchez-Lloret J, et al. (1990) Lung structure and gas exchange in mild chronic obstructive pulmonary disease. Am Rev Respir Dis 141: 895-901. (Pubitemid 20157716)
14. Chin RC, Guenette JA, Cheng S, Raghavan N, Amornputtisathaporn N, et al. (2013) Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease? Am J Respir Crit Care Med 187: 1315-1323.
15. Rodruíguez-Roisin R, Drakulovic M, Rodríguez DA, Roca J, Barberà JA, et al. (2009) Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol 106: 1902-1908.
16. Babb TG, Viggiano R, Hurley B, Staats B, Rodarte JR (1991) Effect of mild-tomoderate airflow limitation on exercise capacity. J Appl Physiol 70: 223-230.
17. O'Donnell DE, Laveneziana P, Ora J, Webb KA, Lam YM, et al. (2009) Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 64: 216-223.
18. Global Initiative for Chronic Obstructive Lung Disease (2014) Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. January 2014. Available: http://www.goldcopd.org/Guidelines/ guidelines-resources.html. Accessed 2014 January 27.
19. O'Donnell DE, Guenette JA, Maltais F, Webb KA (2012) Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 141: 753-762.
20. Hsia D, Casaburi R, Pradhan A, Torres E, Porszasz J (2009) Physiological responses to linear treadmill and cycle ergometer exercise in COPD. Eur Respir J 34: 605-615.
21. Mahler DA, Gifford AH, Waterman LA, Ward J, Machala S, et al. (2011) Mechanism of greater oxygen desaturation during walking compared with cycling in patients with COPD. Chest 140: 351-358.
22. Palange P, Forte S, Onorati P, Manfredi F, Serra P, et al. (2000) Ventilatory and metabolic adaptations to walking and cycling in patients with COPD. J Appl Physiol 88: 1715-1720. (Pubitemid 30336923)
23. Mahler DA, Weinberg DH, Wells CK, Feinstein AR (1984) The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 85: 751-758. (Pubitemid 14121920)
24. MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, et al. (2005) Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 26: 720-735. (Pubitemid 41448672)
25. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) Standardisation of spirometry. Eur Respir J 26: 319-338. (Pubitemid 41079078)
26. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, et al. (2005) Standardisation of the measurement of lung volumes. Eur Respir J 26: 511-522. (Pubitemid 41264217)
27. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, et al. (1993) Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16: 5-40.
28. Porszasz J, Casaburi R, Somfay A, Woodhouse LJ, Whipp BJ (2003) A treadmill ramp protocol using simultaneous changes in speed and grade. Med Sci Sports Exerc 35: 1596-1603. (Pubitemid 37087592)
29. Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14: 377-381.
30. Gandevia B, Hugh-Jones P (1957) Terminology for measurements of ventilatory capacity; a report to the Thoracic Society. Thorax 12: 290-293.
31. Deesomchok A, Webb KA, Forkert L, Lam YM, Ofir D, et al. (2010) Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity. COPD 7: 428-437.
32. Macklem PT (2010) Therapeutic implications of the pathophysiology of COPD. Eur Respir J 35: 676-680.
33. American Thoracic Society, American College of Chest Physicians (2003) ATS/ ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167: 211-277.
34. Allaire J, Maltais F, Doyon JF, Noël M, LeBlanc P, et al. (2004) Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax 59: 673-678. (Pubitemid 39061530)
35. Clark CJ, Cochrane LM, Mackay E, Paton B (2000) Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training. Eur Respir J 15: 92-97. (Pubitemid 30068942)
36. Malerba M, Ragnoli B, Salameh M, Sennino G, Sorlini ML, et al. (2011) Subclinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease. J Biol Regul Homeost Agents 25: 443-451.
37. Kabitz HJ, Walterspacher S, Walker D, Windisch W (2007) Inspiratory muscle strength in chronic obstructive pulmonary disease depending on disease severity. Clin Sci (Lond) 113: 243-249. (Pubitemid 47372682)
38. Morgan MD, Singh SJ (2007) Assessing the exercise response to a bronchodilator in COPD: time to get off your bike? Thorax 62: 281-283. (Pubitemid 46580565)
39. Coronell C, Orozco-Levi M, Méndez R, Ramirez-Sarmiento A, Gáldiz JB, et al. (2004) Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 24: 129-136. (Pubitemid 39029078)
40. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, et al. (2010) The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 36: 81-88.